◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Delta-Fly Pharma,Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
+Operating Income -1.7B -1.4B -1.3B -961.5M -852.2M
Operating Margin % 99.4% 98.4% 99.2% 99.7% 99.2%
Non Operating Income 348,000 16,000 45,000 190,000 438,000
Non Operating Expenses 10.8M 23.4M 10.0M 2.8M 7.6M
+Ordinary Income -1.7B -1.4B -1.3B -964.1M -859.4M
Revenue Growth % -20.4% -7.6% -37.5% -12.2% --
Income Before Taxes -1.7B -1.4B -1.3B -964.1M -859.4M
Income Taxes 2.5M 2.5M 3.0M 3.2M 3.2M
+Net Income -1.7B -1.4B -1.3B -967.3M -862.6M
Net Margin % 100.1% 100.2% 100.2% 100.3% 100.4%
Eps -195.58 -198.78 -234.51 -178.58 -187.34
Depreciation Amortization 1.6M 1.5M 1.6M 1.7M 2.0M
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Cash And Deposits 338.8M 1.4B 844.3M 1.3B 2.1B
Current Assets 394.7M 1.4B 866.2M 1.3B 2.1B
Property Plant Equipment 36.8M 38.2M 38.6M 39.9M 41.6M
Noncurrent Assets 39.7M 41.2M 40.6M 43.5M 45.9M
Total Assets 434.3M 1.5B 906.8M 1.3B 2.2B
Current Liabilities 156.5M 241.5M 115.6M 91.2M 82.5M
Total Liabilities 156.5M 241.5M 115.6M 91.2M 82.5M
Retained Earnings -9.9B -8.2B -6.8B -5.5B -4.5B
Total Equity 277.8M 1.2B 791.2M 1.2B 2.1B
Equity Ratio 0.64 0.84 0.87 0.93 0.96
Book Value Per Share 28.36 149.69 123.91 227.41 390.87
Num Employees 13.00 13.00 11.00 12.00 11.00
Roe -- -- -- -- -0.42
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Operating Cash Flow -1.8B -1.3B -1.3B -940.4M -726.6M
Investing Cash Flow -206,000 207,000 -326,000 -- -505,000
Financing Cash Flow 756.7M 1.9B 882.6M 119.9M 875.3M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...